| Welcome to the KCAS Quartlery Newsletter. Stay up to date with how we continue to advance science through curiosity. If you are having trouble reading our newsletter, view the Web Version. |
 |
| Past News | Article Archive | KCAS Services | Request Information | KCASbio.com |
In This Issue:
Dried Blood Spot Analysis: KCAS unveils a better way. Learn if your drug is a good candidate for this technique.Meet Our New CEO: Dr. Terry Osborn ushers in a new era for KCAS. Take a look at the man leading the operation and innovation at our lab. Research Excellence in KC: New study shows among research hubs in the US, Kansas City shines. |
Dried Blood Spot Analysis Presents New Opportunities
More and more, our clients want to know if Dried Blood Spot (DBS) analysis is a suitable technique for pre-clinical and clinical studies. Among those advantages, sample sizes can be reduced, biohazard risks avoided and lessened subject stress. KCAS is committed to our clients' success and sees tremendous advantage to the use of this technique. Dr. Gene Ray explains more in his brief about the pros and cons of DBS analysis.Read Full Article | Email Feedback |
Don't Miss Another Issue!Sign up for our quarterly newsletter today! |
Introducing: Dr. Terry Osborn A lifelong entrepreneur and leader in the bioscience community, Dr. Terry Osborn took over at KCAS in May of this year. Since then, Terry has reiterated his commitment to excellence for KCAS with an eye to the future of bioanalysis. Read Full Article | Email Feedback |
|
Upcoming Events: ASRM Oct.15-19, Orlando We Want Your Feedback! Is there something you want to see more of in our next newsletter? Something you want to see less of? Let us know! |
Research Excellence in the Heart of AmericaThe Heart of America is the heart of contract research according to a study conducted by Massachusetts - based Simon Management Group. The study reveals Kansas City is an area rich with resources that big pharma and startup biotechs look to in supporting research programs. In the past three years, nearly every major pharmaceutical company has partnered with a Kansas City-based organization with expertise in each phase of research. The CROs in Kansas City account for over 9,000 jobs in the metro area. |
Email Admin CenterThis newsletter is a service of example.com. Should you no longer wish to receive these messages please go here to unsubscribe or send an email to: inquiry@kcasbio.com  |